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    Presenilin 1 (PS1), a causative molecule of familial Alzheimer’s disease (AD), is known to be an unprimed 
substrate of GSK3 (Twomey et al. 2006) and is phosphorylated at serine 353, 357 residues in its cytoplasmic 
loop region (Kirschenbaum et al. 2001). In this report, we investigated the effect of PS1 phosphorylation on 
AD pathophysiology and obtained two important results – PS1 phosphorylation increased A42/40 ratio, and 
PS1 phosphorylation was enhanced in the human AD brains. Interestingly, we demonstrated that PS1 
phosphorylation promoted Insulin Receptor (IR) cleavage and the IR intracellular domain (IR ICD) generated 
by γ-secretase led to a marked transactivation of Akt (PKB), which down-regulated GSK3activity. Thus, the 
cleavage of IR by γ-secretase can inhibit PS1 phosphorylation in the long run. Taken together, our findings 
indicate that PS1 phosphorylation at serine 353, 357 residues can play a pivotal role in the pathology of AD and 
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Alzheimer’s disease (AD) is pathologically characterized by amyloid plaques and neurofibrillary tangles 
(NFTs). Amyloid plaques are composed of amyloid (A) peptides, which are derived from amyloid precursor 
protein (APP) via proteolytic cleavage by γ-secretase (De Strooper et al. 1998). γ-Secretase is an enzymatic 
complex composed of at least four proteins: Presenilin 1 or Presenilin 2 (PS1 or PS2), Nicastrin, Pen 2, and Aph 
1, with Presenilin representing the catalytic core (Yu et al. 2000; Francis et al. 2002; Goutte et al. 2002). PS1 
mutations account for the majority of cases of familial AD, and more than 170 pathogenic mutations have 
been identified within the PS1 coding sequence. On the other hand, NFTs are characterized by the 
accumulation of hyperphosphorylated Tau in neurons (Grundke-Iqbal et al. 1986). One of the candidates 
which phosphorylate Tau is Glycogen synthase kinase 3  (GSK3) (Hanger et al. 1992). 
    GSK3 originally known to inactivate glycogen synthesis, is a serine/threonine protein kinase with a 
wide variety of substrates, and is expressed in various tissues with the highest level in the brain (Grundke-Iqbal 
et al. 1986). Interestingly, GSK3 phosphorylates not only Tau but also PS1 at serine 353, 357 residues in its 
cytoplasmic loop region (Kirschenbaum et al. 2001, Twomey et al. 2006). Therefore, it is intriguing to 
examine the function of PS1 phosphorylation at those residues to connect two AD hallmarks amyloid plaques 
and NFTs. Although our recent report demonstrated that GSK3mediated PS1 phosphorylation regulates the 
localization of γ-secretase and inhibits its N-cadherin cleavage (Uemura et al. 2007), a direct impact of PS1 
phosphorylation on AD pathogenesis has not been elucidated so far.  
    Here, we demonstrate that GSK3mediated PS1 phosphorylation inhibits APP cleavage by γ-secretase 
activity and decreases the total A production whereas it increases A 42/40 ratio. Importantly, we found that 
PS1 phosphorylation was enhanced in the human AD brains. To further elucidate the underlying mechanisms 
which regulate PS1 phosphorylation, we focused on insulin signaling. We observed that phosphorylated PS1 
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promotes the cleavage of IR by γ-secretase activity. Intracellular domain of IR (IR ICD), produced by the 
cleavage, enhances the transcription of Akt (PKB), leading to inhibit GSK3 activity. Therefore, we propose 
that PS1, localized downstream of GSK3, may play a pivotal role in A production under the influence of 























2. Experimental procedures  
 
2.1 Human brain samples 
    From the brain tissue collection in Tokyo Institute of Psychiatry (H.A.), which mainly consists of 
cases from psychogeriatric wards, we employed experiments of six dementia patients’ brains with 
CERAD plaque score 'C' (Mirra et al. 1991) and Braak and Braak’s neurofibrillary tangles (NFTs) stage 
IV or higher (Braak and Braak 1991), as those with AD, as well as five control subjects without 
neurological complications (Table). Fresh-frozen samples were taken in all cases from the mediobasal 
temporal neocortex. The brain samples were extracted in RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 1% 
Triton X100, 1% NP-40, 0.5% Deoxycholate, 0.1% SDS, pH 8.0) with protease inhibitor cocktail (Roche) and 
sufficiently homogenized on ice. Then the samples were incubated for one night at 4ºC and centrifuged at 
14,000 g × 20 min. The supernatants were directly used for Western blot analysis. All autopsies were 
undertaken with written consents and the study was approved by the official ethical committees of Kyoto 
University as well as of Tokyo Institute of Psychiatry. 
 
2.2 Plasmid constructs  
    The pcDNA3.1-hIR (human Insulin Receptor) construct was a kind gift from Dr. Ikeuchi (Niigata 
University, Japan) (Ebina et al. 1985). The cDNA encoding the IR ICD was generated by polymerase chain 
reaction (PCR) using the following primers: IR ICD forward, 
CGGGTACCCGCCATGAGAAAGAGGCAGCCAGA, and IR ICD reverse, 
CGGGATCCGGAAGGATTGGACCGAGGCAA. The PCR product was subcloned into the reading frame of 
the Kpn1/BamH1 sites of the pcDNA3 with HA tag vector. The construction of the plasmids expressing wt PS1, 
pseudo-phosphorylation PS1 (S353/357D PS1), deletion mutant PS1 (Δ340-350 PS1), and dominant negative 
PS1 (D385A PS1) was described previously (Uemura et al. 2003; Uemura et al. 2007). Precise cloning of all 
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reading frames was verified by sequencing. 
 
2.3 Cell culture and transfection 
    SH-SY5Y (derived from human neuroblastoma) cells were maintained in Opti-MEM containing 10 % fetal 
bovine serum (FBS) (Invitrogen). Establishment of cell lines which stably express hIR was described previously 
(Maesako et al. 2010). PS1/PS2 double knockout mouse embryonic fibroblast (MEF PS-/-) cells were 
generously donated by Dr. B De Strooper and they were maintained in Dulbecco’s modified Eagle’s medium 
(DMEM) (SIGMA) with 10% FBS. CHO cells stably expressing both Swedish mutant APP 
(K670M/N770L) and human N-cadherin (APPsw/Ncad-CHO cells) were obtained and maintained as 
described previously (Uemura et al. 2007). For transient transfection into SH-SY5Y as well as into MEF 
PS-/- cells, cells were plated in 6-cm dishes with serum-containing medium. 8 µg of plasmid DNA and 20 µl of 
TransFectin reagent (Bio-Rad) were mixed into 1 ml of serum-free medium and incubated for 20 min, then 
added directly to confluent cells in 2 ml of serum-containing medium. 24 to 48 hrs after transfection, reporter 
gene activity was assayed. 
 
2.4 Antibodies and chemical reagents 
    Anti-IR, a monoclonal antibody recognizing the C-terminal amino acid residues of human IR, was from 
Neo Markers. Rabbit polyclonal anti-Akt and phospho-GSK3 (S9) were from Cell Signaling Technology. 
Mouse monoclonal anti-GSK3was from BD Transduction Laboratories. Mouse monoclonal anti--actin and 
rabbit polyclonal anti-APP C-terminal antibodies were from SIGMA. Rabbit polyclonal anti-PS1 NTF and goat 
polyclonal phospho-PS1 (S353/357) antibodies were from Santa Cruz. Mouse monoclonal PS1 CTF antibody 
was from Calbiochem. Alexa Fluor 546 anti-mouse IgG and Alexa Fluor 488 anti-goat IgG were obtained from 
Molecular Probes. γ-secretase inhibitor DAPT and L-685458 were from SIGMA. Akt inhibitor IV, TPA, and 




2.5 Western blotting 
    Cells were washed in phosphate-buffered saline (PBS) two times and scraped off. Cell pellets were 
suspended in ice-cold TNE buffer (10 mM Tris HCl, 150 mM NaCl, 1% NP-40, 1 mM EDTA pH 7.8), 
supplemented with protease inhibitor cocktail, and brieﬂy subjected to sonication. The samples were 
centrifuged at 14,000 g × 20 min at 4°C and the supernatants were collected to obtain protein samples. 
The protein concentration was determined using the Bradford assay (Bradford 1976). Protein samples 
were diluted with sample buffer (125 mM Tris, 4% SDS, 2% 2-mercaptoethanol, 20% glycerol and 0.01% 
bromophenol blue, pH 6.8) and denatured at 95°C for 5 min. Samples containing equal amounts of 
protein were electrophoresed on polyacrylamide gradient gels (5–20%) (Atto, Japan) in running buffer 
(25 mM Tris, 192 mM glycine, 0.1% SDS). In this gel, APP CTFs bands were shown as a single band. To 
detect AICD, samples were electrophoresed on 15% Tricine gels (Atto, Japan) in Tricine SDS Running 
Buffer. Immunoblotting was carried out by transferring the proteins to polyvinylidene diﬂuoride 
microporous membrane, blocking this membrane with 5% skimmed milk in 20 mM TBS containing 0.1% 
Tween 20 (TBS-T), and incubating with the primary antibodies in PBS containing 4% bovine serum 
albumin (BSA) (Nacalai tesque) overnight at 4°C. The membranes were then washed in TBS-T and 
incubated with a horseradish peroxidase-conjugated anti-mouse IgG (GE Healthcare) in TBS-T for 1 hr at 
room temperature. The speciﬁc reaction was visualized using the enhanced chemiluminescence (ECL) 
method (GE Healthcare).  
 
2.6 In vitro γ-secretase assay 
    To analyze AICD or IR ICD level by in vitro γ-secretase assay (Sastre et al. 2001), cells were 
suspended (0.5 ml/10 cm dish) in homogenization buffer (10 mM MOPS, 10 mM KCl, pH 7.0) and 
homogenates and the post-nuclear supernatant (PNS) were prepared as described (Steiner et al. 1998). 
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Membranes were pelleted from the PNS by centrifugation for 20 min at 16,000 g at 4°C, washed with 
homogenization buffer and resuspended (50 µl/10 cm dish) in assay buffer (150 mM sodium citrate, pH 
6.4). To allow generation of ICD, samples were incubated at 37°C for 2 hrs in a volume of 25 µl/ assay. 
Control samples were kept at 4°C. After termination of the assay reactions, samples were separated into 
pellet fractions (membrane fractions) and supernatant fractions by ultracentrifugation for 1 hr at 100,000 g 
at 4°C. AICD was detected using polyclonal anti-APP C-terminal antibody and IR ICD was detected 
using monoclonal anti-IR C-terminal antibody. 
 
2.7 Immunostaining 
    5.0 × 104 cells were harvested onto 0.1% polyethyleneimine-coated Lab-Tek II Chamber slides (4- 
well; Nalge Nunc International, Rochester) and maintained in Opti-MEM containing 10% FBS. Cells 
were cultured for the indicated time and then ﬁxed with 4% paraformaldehyde for 20 min. Fixed cells 
were blocked with PBS containing 0.2% Triton X-100 for 15 min and incubated overnight at 4°C with 
each antibody diluted in PBS containing 3% BSA. Immunoreactivity was visualized using the 
species-speciﬁc secondary antibodies mentioned above. The samples were examined using a laser 
confocal scanning microscope, LSM 510 Pascal (Zeiss).  
 
2.8 Measurement of extracellular A 
    The levels of Aβ 40 and Aβ 42 were measured by ELISA kits specific to Aβ 40 and Aβ 42 (Wako, 
Japan), as described previously (Uemura. et al 2009). Briefly, APPsw/Ncad-CHO cells were cultured in 6 
cm dishes at a density of 7.0 × 105 cells /well. 24 hrs after incubation, the cells were treated with reagents 
for 5 hrs in DMEM/F-12 medium, followed by replacing DMEM/F-12 with 6 ml of Opti-MEM. 1 hr after 
replacing, 1 ml of medium was collected, centrifuged at 600 g for 5 min, and 100 µl of the aliquot was 




2.9 MTT assay 
The viability in APPswe/N-cad-CHO cells was analyzed by MTT assay using MTT Cell Proliferation 
Assay Kit (Cayman Chemical Company, USA). Briefly, cells were cultured in a 96-well plate at a density of 1.0 
× 104 cells /well. 24 hrs after incubation, reagents of indicated concentration were treated for 5 hrs in the 
presence of DMEM/F-12 medium, followed by replacing DMEM/F-12 to 100 μl of Opti-MEM with the 
reagents. 1 hr after replacing, MTT was measured using the Kit and microplate reader.  
 
2.10 Real-time PCR assay 
    Total RNA was isolated using ISOGEN (NIPPON GENE, Japan), according to the manufacture’s protocol. 
For real-time PCR analysis, 5 µg total RNA from each sample was used for cDNA synthesis kit (GE 
Healthcare). Real-time PCR primers were designed as follows: Akt1: fw GACCTCAAGCTGGAGAAC / rv 
ACTGCACGGCCGTAGTC, Akt2: fw ACCGCCTGTGCTTTGTGATG / rv TCATTGTCCTCCAGCACCTC 
Akt3: fw CATTATTGCAAAGGATGAAGTGGCAC / rv CCAGCATTAGATTCTCCAACTTGAG.  
For the ampliﬁcation of Akt, 5 µl of cDNA was added to the SYBR green master mix (Roche) and real-time 
PCR assay was performed in LightCycler 480 (Roche). 
 
2.11 Statistical analysis  
    All values are given in means ± SE. Comparisons were performed using an unpaired Student’s t-test. For 
comparison of multiparametric analysis, one-way factorial ANOVA, followed by the post hoc analysis by 
Fisher’s PLSD was used. p < 0.05 was considered to indicate a significant difference. n = 4 indicated four 







3.1 PS1 phosphorylation inhibits APP cleavage but enhances extracellular A42/40 ratio 
    Since PS1 is known to be the essential component of γ-secretase, we examined the effect of its 
phosphorylation on APP cleavage. To test this, we transfected wt PS1 and pseudo-phosphorylated PS1 
mutant S353/357D PS1 (in which serine residues phosphorylated by GSK3 are substituted with aspartate to 
mimic phosphorylation state (Uemura et al. 2007)) into MEF PS-/- cells. Transfected cells were treated with 
insulin to promote ectodomain shedding (Linda et al. 2007) and to inhibit the phosphorylation of wt PS1 
(Maesako et al. 2010). APP CTFs band was accumulated in MEF PS-/- cells (Fig. 1A, 1st lane). Interestingly, in 
the absence of insulin, the level of APP CTFs was slightly higher in S353/357D PS1 cells than that in wt PS1 
(Fig. 1A, 2nd and 3rd lanes). Moreover, in the presence of insulin, the level of APP CTFs in S353/357D PS1 
was significantly increased compared to that in wt PS1 (Fig. 1A, 4th and 5th lanes, Fig. 1B). Using Tricine gels, 
we could detect that the level of APP ICD (AICD) in S353/357D PS1 was decreased compared to that in wt 
PS1 (Fig. 1C, 3rd and 4th lanes). This result was confirmed by in vitro γ-secretase assay (Fig. 1D). Collectively, 
these results suggested that PS1 phosphorylation inhibited the γ-secretase-mediated cleavage of APP CTFs.  
    As A plays a pivotal role in the pathogenesis of AD, we next examined the effect of PS1 
phosphorylation on extracellular Aproduction, as well as A42/40 ratio. For this purpose, either Akt 
inhibitor IV or LiCl, which activates or inhibits GSK3 respectivelywas added to change the 
phosphorylation status of PS1 in APPswe/N-cad-CHO cells (Fig. 1E). Under this condition, neither of 
them induced cell death (Fig. 1F). Interestingly, Akt inhibitor significantly decreased the amount of 
extracellular A40whereas LiCl significantly increased its amount (Fig. 1G). In contrast, the extracellular 
A42level in the presence of either Akt inhibitor or LiCl remained almost the same (Fig. 1H), thus 
leading to the increase of A42/40 ratio in Akt inhibitor-treated cells or to the decrease of its ratio in 
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LiCl-treated cells (Fig. 1I). These results collectively indicate that GSK3mediatedPS1 phosphorylation 
down-regulated Aproduction but enhanced A ratio.  
 
3.2 PS1 phosphorylation is enhanced in AD human brain samples 
    It was reported that GSK3 activity was up-regulated in AD brains (Bhat et al. 2004). Therefore, we 
assumed that the phosphorylation ratio of PS1 might be increased in AD brains. Thus, we analyzed the 
phosphorylation ratio of PS1 in human brains. In order to rule out the post-mortem effect on the phosphorylation 
state of PS1 and GSK3, we examined the levels of PS1 and GSK3phosphorylation in mouse brains with 
different post-mortem intervals and demonstrated that post-mortem intervals did not influence the 
phosphorylation ratio of either PS1 or GSK3 up to 36 hrs after sacrifice (data not shown). In accordance 
with the previous reports, the phosphorylation ratio of GSK3 S9 was significantly decreased in AD brains 
compared with that in control brains (Fig. 2A, 3rd and 4th rows, Fig. 2B), indicating the hyperactivity of GSK3 
in AD brains. In contrast, PS1 phosphorylation was significantly increased in AD brains compared with that in 
control ones (Fig. 2A, 1st and 2nd rows, Fig. 2C). These results suggest that up-regulated GSK3 activity could 
enhance PS1 phosphorylation in AD-affected brains.  
 
3.3 PS1 phosphorylation promoted IR cleavage 
    Since IR is one of key regulators of GSK3 activity, we analyzed the functional relationship between 
PS1/-secretase activity and IR. It is now reported that γ-secretase processes IR, a main player of insulin 
signaling, along with other substrates (Kasuga et al. 2007; Marambaud et al. 2002; Okamoto et al. 2001). As 
reported previously, ectodomain shedding of IR -subunit by metalloproteases generates a membranous 
fragment  IR CTF (Fig. 3A, bottom), which is further cleaved by γ-secretase to produce the intracellular 
domain  IR ICD (Fig. 4A, bottom). For the analysis of IR cleavage, we co-transfected either wt PS1 or 
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S353/357D PS1 together with IR into MEF PS-/- cells, followed by insulin treatment. In the absence of insulin, 
IR CTF level was slightly higher in wt PS1 cells than that in S353/357D PS1 cells (Fig. 3B, 2nd and 3rd lanes). 
Moreover, insulin treatment led to a robust increase in the level of IR CTF in wt PS1 when compared to 
that in S353/357D PS1 (Fig. 3B, 4th and 5th lanes, Fig. 3C). In addition, we examined the level of IR ICD using 
in vitro γ-secretase assay and demonstrated that IR ICD level in S353/357D PS1 cells was higher than that in wt 
PS1 cells (Fig. 3D). These results suggested that PS1 phosphorylation enhanced the γ-secretase-mediated 
cleavage of IR CTF.  
    Since phosphorylation of PS1 reduces the PS1/N-cadherin/-catenin interaction (Uemura et al. 2007), we 
asked whether the PS1 interaction with N-cadherin/-catenin directly affects IR cleavage. To test this, MEF 
PS-/- cells were co-transfected with IR and Δ340-350 PS1 (a deletion mutant lacking the loop domain necessary 
for the interaction with N-cadherin/-catenin (Uemura et al. 2007)), followed by insulin treatment. As in 
S353/357D PS1 transfected cells (Fig. 3E, middle lane), the level of IR CTF in Δ340-350 PS1 transfected cells 
was significantly decreased compared to that in wt PS1 cells (Fig. 3E, left and right lanes, Fig. 3F). These 
findings were also confirmed in neuronal cells (Fig. 3G). Collectively, these results indicated that dissociation of 
PS1 from N-cadherin/-catenin as well as phosphorylation of PS1 promotes the cleavage of IR by γ-secretase. 
 
3.4 IR intracellular domain up-regulates the transcription of Akt 
Several lines of evidence suggest that the cleavage of membrane protein by γ-secretase, known as regulated 
intramembrane proteolysis (RIP), is linked to intracellular signaling events (Wolfe et al. 2004; Maetzel et al. 
2009). γ-secretase generates the intracellular domain (ICD) of the membranous proteins, resulting in the release 
of ICD from the membrane. Some ICDs translocate to the nucleus and act as transcription regulators. IR ICD 
also translocates to the nucleus (Kasuga et al. 2007), but its exact function remains unknown.     
    To examine the cellular consequence of IR-RIP, we transfected IR ICD fused with HA-Tag (Fig. 4A, 
bottom) into SH-SY5Y cells. Immunostaining with anti-HA antibody revealed that IR ICD was located at the 
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nucleus as in the previous report (Fig. 4B, under panel), whereas full length IR was located at the cell membrane 
and in the cytoplasmic region (Fig. 4B, top panel). In order to analyze the effect of IR ICD translocation into 
the nucleus we transiently transfected IR ICD into native SH-SY5Y cells. 36 hrs after transfection, mRNA was 
extracted and analyzed by real-time PCR assay. In this experiment, we focused on the mRNA level of Akt, 
because Akt plays important roles in IR signaling. Since Akt has three isoforms – Akt 1, 2 and 3, we evaluated 
mRNA level of all the isoforms. mRNA levels of Akt 1 and 2 were significantly increased in IR ICD transfected 
cells, compared with those in control cells (Fig. 4C). The protein level of total Akt was also significantly 
increased in IR ICD transfected cells 48 hrs after transfection (Fig. 4D and E), suggesting marked 
transactivation of Akt in IR ICD transfected cells. Moreover, under the same condition, we observed that IR 
ICD reduced GSK3 activity, promoted GSK3 S9 phosphorylation, as well as enhanced Akt levels (Fig. 4F 
and G). These results collectively indicate that IR ICD can enhance Akt transcription, followed by the reduction 
in GSK3 activity. 
 
3.5 PS1/γ-secretase-mediated IR cleavage changes the expression level of Akt   
    To confirm that IR-RIP regulates the transcription of Akt, we modulated IR cleavage in several ways. First, 
we inhibited γ-secretase activity and observed the expression level of Akt. After a 24 hr DAPT treatment, the 
level of Akt did not change in SH-SY5Y cells which have little endogenous IR (data not shown). On the other 
hand, the expression level of Akt was dose-dependently decreased in SH-SY5Y wt IR cells (Fig.5A, top row), 
indicating that inhibition of γ-secretase led to decrease the levels of Akt. These results were confirmed by the 
treatment with another γ-secretase inhibitor, L-685458 (data not shown), and by non-pharmacological inhibition 
(Fig. 5B, middle and right lanes), using D385A PS1, which dominant-negatively inhibits γ-secretase activity 
(Uemura et al. 2003).     
    It was reported that IR might undergo ectodomain shedding by metalloproteases such as ADAM 17 
(Kasuga et al. 2007). Since protein kinase C activation enhances the metalloprotease-mediated ectodomain 
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shedding (Ni et al. 2001), we treated SH-SY5Y wt IR cells with 500 nM TPA to enhance the ectodomain 
shedding. In the presence of L-685458, TPA treatment for 24 hrs increased the level of IR CTF, indicating that 
ectodomain shedding of IR was promoted by TPA (Fig. 5C. 3rd and 5th lanes). To analyze its effect on Akt levels, 
SH-SY5Y wt IR cells were pre-incubated with either DAPT or vehicle (DMSO) for 18 hrs, followed by TPA 
treatment with or without DAPT. Interestingly, in the absence of DAPT, the expression level of Akt was 
increased (Fig. 5D, 5th lane, Fig. 5E). Conversely, TPA treatment in the presence of DAPT significantly 
decreased the level of Akt (Fig. 5D, 4th and 6th lanes). Similarly, treatment with PKC inhibitor for 24 hrs in 
different concentrations demonstrated the dose-dependent decrease of Akt levels (data not shown). Taken 




















    Previous reports demonstrated that GSK3 activity is up-regulated in AD brains (Bhat et al. 2004). On the 
other hand, conditional transgenic mice overexpressing GSK3in the adult brain show clear evidence of 
neurodegeneration (Lucas et al. 2001). Moreover, aberrantly activated GSK3 phosphorylates Tau, which leads 
to NFTs (Hanger et al. 1992). This evidence clearly indicated that GSK3plays essential roles in the pathology 
of AD. Importantly, we and other groups previously reported that PS1, a causative molecule of familial AD, was 
also phosphorylated by GSK3 at serine 353, 357 residues (Kirschenbaum et al. 2001, Twomey et al. 2006, 
Uemura et al. 2007). Since most of the familial AD-linked PS1 mutations affect APP metabolism, in the 
present study, we examined the effect of PS1 phosphorylation on APP cleavage by PS1/-secretase Our 
analysis using S353/357D mutant PS1 revealed that phosphorylated PS1 significantly inhibited the cleavage of 
APP CTFs by -secretase (Fig. 1A-D). Furthermore, the ELISA results indicated that PS1 phosphorylation 
reduced extracellular A40levels without changing extracellular Alevels, thereby increasing the A 
ratio (Fig. 1E-G). Similar phenomena were observed in the familial AD-linked PS1 mutations (Selkoe and 
Wolfe 2007). Accumulating evidence suggests that partial loss of function in γ-secretase may lead to an 
increased Aratio as well as to neurodegeneration (Shen 2007, Wolfe 2007). In addition, a recent report 
suggested that Amay inhibit Adeposition and thus may be physiologically neuroprotective (Kim et al. 
2007). Thus, PS1 phosphorylation-mediated reduction of A and increase of A ratio can aggravate 
the pathology of AD. So far, the significance of PS1 modification including phosphorylation has not yet been 
fully investigated in AD brains. Importantly, our in vivo study clearly showed accelerated PS1 phosphorylation 
in sporadic AD patient brains (Fig. 2). Considering these results, the disruption of the balance of PS1 
phosphorylation may lead to neurodegeneration via aberrant GSK3 activity. 
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    In addition, we searched for the mechanisms inhibiting PS1 phosphorylation. In the present study, we found 
a novel role of γ-secretase-mediated IR cleavage as a protective safeguard from aberrant GSK3 activity. IR is 
widely distributed in the brain with particularly high concentrations in neurons, both in the cell bodies as well as 
in synapses (Werther et al. 1987, Marks et al. 1991). IR is a known substrate for γ-secretase and IR ICD 
translocates to the nucleus upon -secretase-mediated cleavage (Kasuga et al. 2007). In this report, we showed 
that IR ICD activates the transcription of Akt (Fig. 4), a key element in multiple biological processes including 
glucose metabolism, cell survival, cell growth, cell differentiation, and angiogenesis (Franke et al. 2003; 
Fayard et al. 2005; Song et al. 2005). Notably, we observed that PS1 phosphorylation promoted the 
γ-secretase-mediated cleavage of IR (Fig. 3). Thus, GSK3 activation may promote the phosphorylation of PS1 
to enhance cleavage of IR, finally activating the transcription of Akt, which is a strong inhibitor of GSK3 
activity. This phenomenon may constitute a negative feedback mechanism, which up-regulates Akt when 
GSK3 is aberrantly activated. Interestingly, this is contrary to the case of the cleavage of N-cadherin, since 
N-cadherin cleavage is down-regulated by the phosphorylation of PS1 (Uemura et al. 2007). Thus, the 
phosphorylation status of PS1 may explain in part the substrate specificity in various conditions.  
    In conclusion, we propose that GSK3-mediatedPS1 phosphorylation, acting as a link between GSK3 
activity and A generation, may play a pivotal role in AD pathogenesis under the influence of insulin signaling. 
As our study indicated that GSK3-mediated phosphorylation of PS1 increases the A42/40 ratio, modulating 
GSK3 activity can be a good therapeutic strategy, aiming at both the inhibition of tau phosphorylation and the 
reduction of A42/40 ratio. Thus, IR cleavage could be one of the potential regulatory mechanisms affecting 
GSK3 activity as a negative feedback mechanism; disruption of IR cleavage may lead to increased GSK3 
activity, as well as A42/40 ratio. Therefore, the in vivo regulatory mechanism of controlling PS1 function 
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7. Figure legends 
 
7.1 Fig. 1. PS1 phosphorylation inhibits APP cleavage but enhances extracellular A42/40 ratio 
A. Either wt PS1 or pseudo-phosphorylation PS1 mutant (S353/357D PS1) was transfected into MEF 
PS-/- cells. Control cells were transfected with pcDNA (first lane). 24 hrs after transfection, cells were 
treated with 50 nM insulin for 30 min (4th and 5th lanes). 
B. APP CTFs were normalized by housekeeping gene (β-actin) and relative band density was 
quantitatively analyzed (n = 3). 
C. Either wt PS1 or S353/357D PS1 was transfected into MEF PS-/- cells and APP ICD was detected by 
Tricin-SDS-PAGE using anti APP-C-terminal antibody. Cells were treated with 500 nM TPA that 
promoted the processing of APP as a positive control. 
D. Membrane preparations from MEF PS-/- cells transfected with pcDNA, wt PS1 or S353/357D PS1 
were incubated at 37°C for 2 hrs. Control samples were kept at 4°C.The reaction mix was then separated 
in pellet fraction as membrane fraction (lower panel) and supernatant fraction (1st and 2nd panels) by 
ultracentrifugation. These fractions were electrophoresed on polyacrylamide gradient gels or Tricine gels 
and immunoblotted with anti APP-C-terminal antibody.  
E. APPsw/Ncad-CHO cells were incubated in Opti-MEM in the presence of 10 μM Akt inhibitor IV or 25 
mM LiCl for 6 hrs. PS1 (S353/357) and GSK3β (S9) phosphorylation were analyzed by immunoblotting, 
using anti-phospho-PS1 S353/357, anti-PS1 CTF, anti-GSK3β and anti-phospho-GSK3β S9 antibodies. 
F.  Cell viability was analyzed by MTT assay. Both 10 μM of Akt inhibitor IV and 25 mM LiCl (GSK 
inhibitor) which were used in this study didn’t induce cell death (n = 10). 100 μM of Akt inhibitor was 
used as positive control. 
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G and H. APPsw/Ncad-CHO cells were incubated in Opti-MEM in the presence of 10 μM Akt inhibitor 
IV or 25 mM LiCl for 6 hrs. DMSO was used as a negative control. After incubation, released 
extracellular Aβ 40 or Aβ 42 for 1 hr were analyzed by ELISA (n = 5). 
I. Extracellular Aβ 42/40 ratio was quantitatively analyzed. 
 
7.2 Fig. 2. PS1 phosphorylation is increased in AD brains 
A. The lysates of human brain samples, including AD and non-AD brains, were analyzed by 
immunoblotting, using anti-phospho-PS1 S353/357, anti-PS1 CTF, anti-GSK3β and anti- 
phospho-GSK3β S9 antibodies. Lording control was detected using anti-β-actin antibody (lower panel). 
B and C. GSK3β and PS1 phosphorylation ratio of each sample was quantitatively analyzed and described 
as a point. The number indicated on the point means average ratio.   
 
7.3 Fig. 3. IR cleavage is promoted by PS1 phosphorylation 
A. A schematic representation of IR CTF. IR-β-subunit is cleaved by metalloproteases at the extracellular 
area, producing IR CTF (bottom).   
B. Either wt PS1 or S353/357D PS1 was co-transfected with IR into MEF PS-/- cells. Control cells were 
transfected with pcDNA (first lane). 24 hrs after transfection, cells were treated with 50 nM insulin for 30 
min (4th and 5th lanes).   
C. IR CTF was normalized by β-actin and relative band density was quantitatively analyzed (n = 3).   
D. Membrane preparations from MEF PS-/- cells co-transfected IR with pcDNA, wt PS1 or S353/357D 
PS1 were incubated at 37°C for 2 hrs. Control samples were kept at 4°C. The reaction mix was then 
separated in pellet fraction as membrane fraction (lower panel) and supernatant fraction (1st and 2nd 
panels) by ultracentrifugation. These fractions were electrophoresed on polyacrylamide gradient gels and 
immunoblotted with anti IR-C-terminal antibody.  
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E. MEF PS-/- cells were transfected with wt PS1, S353/357D PS1 or Δ340-350 PS1 and after 24 hrs of 
transfection, cells were treated with 50 nM insulin for 30 min.   
F. IR CTF was normalized by β-actin and relative band density was quantitatively analyzed (n = 3).  
G. SH-SY5Y wt IR cells were transfected with either wt PS1, S353/357D PS1 or Δ340-350 PS1 and then 
treated with 50 nM insulin for 30 min. 
 
7.4 Fig. 4. IR ICD up-regulates the transcription of Akt 
A. A schematic representation of plasmid construction of IR ICD. The HA tag was fused to the C-terminus 
of IR ICD (bottom). The amino acid of transmembrane domain was indicated (top, gray area).   
B. Native SH-SY5Y cells were transfected with IR ICD or full length (FL) IR. Scale bar, 20μm.   
C. SH-SY5Y cells were transfected with IR ICD. After 36 hrs of transfection, the mRNA levels of Akt 
were analyzed by real-time PCR assay. The mRNA amount of Akt was normalized by that of β-actin (n = 
4).   
D. After 48 hrs of transfection, SH-SY5Y cells were analyzed by immunoblotting.   
E. The expression level of endogenous Akt was quantitatively analyzed (n = 3). The level of Akt was 
normalized by that of β-actin.   
F. After 48 hrs of transfection of IR ICD, the level of phospho-GSK3β S9 was analyzed by 
immunoblotting.   
G. The relative phosphorylation ratio of GSK3β was quantitatively analyzed (n = 3).  
 
7.5 Fig. 5. IR cleavage changes the expression level of Akt 
A. SH-SY5Y wt IR cells were treated with DAPT for 24 hrs in different concentrations (0, 0.1, 0.5, 2, 5 
μM).   
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B. SH-SY5Y wt IR cells were transiently transfected with pcDNA (as a control), wt PS1 and D385A PS1. 
After 48 hrs, the Akt level was analyzed.   
C. SH-SY5Y wt IR cells were treated with 5 μM of DAPT, L-685458, 500 nM of TPA or L-685458 + TPA 
for 24 hrs. Control cells were treated with DMSO.   
D. After pre-incubation with either DAPT or vehicle (DMSO) for 18 hrs, SH-SY5Y wt IR cells were treated 
with 500 nM TPA in the presence of DAPT or DMSO for 24 hrs.   
E. After TPA treatment, the relative expression level of Akt was quantitatively analyzed (n = 4). The level 
of Akt was normalized by that of β-actin.  
 
7.6 Fig. 6. Schematic presentation of cellular events caused by PS1 phosphorylation 
GSK3β-mediated PS1 phosphorylation enhances the extracellular Aβ42/40 ratio and its phosphorylation is 
promoted in the AD brain. Therefore, PS1 phosphorylation may promote the pathology of AD (left panel). 
On the other hand, when GSK3β is aberrantly activated, the phosphorylated PS1 cleaves IR, then activates the 
transcription of Akt, which finally inhibits GSK3β activity (right panel). There may be some mechanisms 
which down-regulate PS1 phosphorylation through inhibition of GSK3β activity and IR cleavage by 
γ-secretase can be one of them. 
 
7.7 Table Characteristics of human brain samples 
We employed experiments of six Alzheimer's disease patients’ brains, as well as five control subjects 
without neurological complications. Fresh-frozen samples were taken in all cases from the mediobasal 
temporal neocortex. There is no statistical difference in the postmortem interval between AD and control 
cases. 
 
 
